HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Google Scholar Articles by Hall, A S Articles by Palmer, S PubMed PubMed Citation Articles by Hall, A S Articles by Palmer, S

The heart rate hypothesis: ready to be tested

¹ British Heart Foundation Heart Research Centre at Leeds, University of Leeds, Leeds, UK
² Centre for Health Economics, University of York, York, UK

Correspondence to:
Professor of Clinical Cardiology, Alistair S Hall, G Floor, Jubilee Wing, Leeds General Infirmary, Leeds, LS2 3EX, UK; A.S.Hall{at}leeds.ac.uk

ABSTRACT
There is increasing evidence that increased heart rate may be an independent risk factor for cardiovascular morbidity and mortality both in patients with ischaemic heart disease and in the general population. Elevated heart rate in coronary artery disease is a major determinant of oxygen consumption and appears to evoke most episodes of ischaemia. Increased resting heart rate may also contribute to the development of atherosclerosis, facilitate plaque destabilisation and initiate arrhythmias, leading to acute coronary events and sudden death. Reducing heart rate is a central aim in the treatment of stable angina pectoris; this therapeutic approach may have an essential role in lowering the incidence of cardiovascular morbidity and mortality in patients with pre-existing ischaemic heart disease. However, this heart rate hypothesis has not thus far been proven. Evidence suggests that the use of heart rate-lowering drugs may have a beneficial effect; however, most treatments for angina have additional negative inotropic effects on the heart. This hypothesis can now be tested following the recent development of selective heart rate drugs.

Keywords: heart rate; If channel inhibitors; ivabradine; angina pectoris; heart rate hypothesis